| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $5.59 ▲ +1.24% | Yesterday | $5.49 ▼ -0.52% | Tomorrow's Atea Pharmaceuticals Inc. Common Stock (AVIR) setup is anchored to $5.52 and targets $5.59 (+1.24%). The near-term read is upside; watch $5.69 / $5.35 because daily realized volatility is about 6.38%. |
Tomorrow's Atea Pharmaceuticals Inc. Common Stock (AVIR) setup is anchored to $5.52 and targets $5.59 (+1.24%). The near-term read is upside; watch $5.69 / $5.35 because daily realized volatility is about 6.38%. | ||||
| Week | $5.73 ▲ +3.85% | Last Week | $5.43 ▼ -1.62% | The 7-day Atea Pharmaceuticals Inc. Common Stock model moves from $5.43 to $5.73 (+3.85%). It gives upside momentum context for this stock, so breaks around $5.69 / $5.35 matter more than a single tick. |
The 7-day Atea Pharmaceuticals Inc. Common Stock model moves from $5.43 to $5.73 (+3.85%). It gives upside momentum context for this stock, so breaks around $5.69 / $5.35 matter more than a single tick. | ||||
| Month | $5.97 ▲ +8.20% | Last Month | $5.33 ▼ -3.44% | The 1-month Atea Pharmaceuticals Inc. Common Stock target is $5.97 (+8.20%), compared with the live reference near $5.52. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Atea Pharmaceuticals Inc. Common Stock target is $5.97 (+8.20%), compared with the live reference near $5.52. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $6.33 ▲ +14.72% | Last Year | $5.18 ▼ -6.18% | The 1-year Atea Pharmaceuticals Inc. Common Stock scenario points to $6.33 (+14.72%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Atea Pharmaceuticals Inc. Common Stock scenario points to $6.33 (+14.72%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $7.18 ▲ +30.00% | 5 Years Ago | $4.82 ▼ -12.60% | The 5-year Atea Pharmaceuticals Inc. Common Stock view is $7.18 (+30.00%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Atea Pharmaceuticals Inc. Common Stock view is $7.18 (+30.00%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $5.52 | Mid |
| Daily Change | -3.33% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 64% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $5.52 | Daily Change | -3.33% |
| Market Cap | $439.79M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.